Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Cynthia R. Giver, PhD, Pamela A Shaw, PhD, Helen Fletcher, PhD, Deepak Kaushal, PhD, Garcia Pamela, Deborah Omoyege, Gregory Bisson, MD, Tawanda Gumbo, MD, Robert Wallis, MD, Edmund K. Waller, PhDMD, Daniel Kalman, PhD

Blood (2019) 134 (Supplement_1): 1050.

https://doi.org/10.1182/blood-2019-130275

Published: 2019

Journal Articles

Diminished Renal Pathology in a Mouse Model of Sickle Cell Anemia in Which Fibrinogen Binding to Mac-1 Is Inhibited

Md Nasimuzzaman, PhD, Paritha I. Arumugam, PhD, Eric S. Mullins, MD, Jeanne M James, MD, Katherine VandenHeuvel, MD, Marilou Narciso, BS, Maureen A. Shaw, MSc, Sarah McGraw, Bruce J. Aronow, PhD, Matthew J. Flick, PhD, Punam Malik, MD

Blood (2018) 132 (Supplement 1): 267.

https://doi.org/10.1182/blood-2018-99-112641

Published: 2018

Journal Articles

Plasmin-Mediated Fibrinolysis Enables Macrophage Migration Via Liberation from Fibrin-α M β 2 Interactions

Eric S. Mullins, MD, Maureen A. Shaw, MSc, Zhen Gao, PhD, Matthew J. Flick, PhD

Blood (2018) 132 (Supplement 1): 136.

https://doi.org/10.1182/blood-2018-99-117018

Published: 2018

Journal Articles

Mice Lacking Factor XIII Have Significant Protection from the Progression of Neuroinflammatory Disease

Zhen Gao, PhD, Maureen A. Shaw, MSc, Joseph S. Palumbo, MD, Matthew J. Flick, PhD, Eric S. Mullins, MD

Blood (2017) 130 (Supplement 1): 237.

https://doi.org/10.1182/blood.V130.Suppl_1.237.237

Published: 2017

Journal Articles

Biomarker Profiling Differentiates Sepsis from Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

Simon F. Lacey, PhD, Pamela A Shaw, PhD, David T Teachey, MD, Scott L. Weiss, MD, Fang Chen, PhD, Vanessa E Gonzalez, M.B.A, Noelle Frey, MD MS, David L Porter, MD, Shannon L Maude, MD PhD, Stephan A Grupp, MD PhD, Edward Pequignot, M.S., Carl H June, MD, Jan J. Melenhorst, PhD

Blood (2016) 128 (22): 2812.

https://doi.org/10.1182/blood.V128.22.2812.2812

Published: 2016

Journal Articles

Plasmin(ogen) Mediates Macrophage Migration in a Fibrin(ogen) Dependent Mechanism

Maureen A. Shaw, M.S., Zhen Gao, PhD, Eric S. Mullins, MD

Blood (2016) 128 (22): 18.

https://doi.org/10.1182/blood.V128.22.18.18

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation in Patients ≥70 Years Old

Christopher C Walling, BS, Pamela A Shaw, PhD, Noelle V Frey, MD, Saar I Gill, MBBS, PhD, Elizabeth O. Hexner, MD, Alison W Loren, MD MS, Selina Luger, MD, James K Mangan, MD PhD, Mary Ellen Martin, MD, Jacqueline Smith, CRNP, Edward A. Stadtmauer, MD, David L. Porter, MD

Blood (2016) 128 (22): 2309.

https://doi.org/10.1182/blood.V128.22.2309.2309

Published: 2016

Journal Articles

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Blood (2016) 128 (22): 217.

https://doi.org/10.1182/blood.V128.22.217.217

Published: 2016

Journal Articles

Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice

Maureen A. Shaw, Keith W. Kombrinck, Kathryn E. McElhinney, David R. Sweet, Matthew J. Flick, Joseph S. Palumbo, Mei Cheng, Naomi L. Esmon, Charles T. Esmon, Alexander Brill, Denisa D. Wagner, Jay L. Degen, Eric S. Mullins

Blood (2016) 128 (5): 721–731.

https://doi.org/10.1182/blood-2015-11-680280

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Anti–miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice

Yuhang Zhou, Shaji Abraham, Pierrette Andre, Leonard C. Edelstein, Chad A. Shaw, Carol A. Dangelmaier, Alexander Y. Tsygankov, Satya P. Kunapuli, Paul F. Bray, Steven E. McKenzie

Blood (2015) 126 (26): 2871–2881.

https://doi.org/10.1182/blood-2015-02-631135

Published: 2015

Includes: Supplemental data

Journal Articles

Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

David T Teachey, MD, Simon F. Lacey, PhD BSc, Pamela A Shaw, PhD, J Joseph Melenhorst, PhD, Noelle V. Frey, MD, Shannon L Maude, MD PhD, David M. Barrett, MD PhD, Richard Aplenc, MD PhD, Fang Chen, PhD, Julie Fitzgerald, MD PhD, Vanessa Gonzalez, M.B.A, Edward Pequignot, PhD, Susan R. Rheingold, MD, Scott Weiss, MD, Jason C. White, DO, Carl H. June, MD, David L. Porter, MD, Stephan A. Grupp, MD PhD

Blood (2015) 126 (23): 1334.

https://doi.org/10.1182/blood.V126.23.1334.1334

Published: 2015

Journal Articles

Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS/Combined Relapsed/Refractory ALL

Susan R. Rheingold, MD, Lanyi Nora Chen, BS, Shannon L Maude, MD PhD, Richard Aplenc, MD PhD, Christine Barker, BS, David M. Barrett, MD PhD, Colleen Callahan, MSN, Katherine Cebry, Irina Kulikovskaya, PhD, Simon F. Lacey, PhD BS, Bruce L. Levine, PhD, Jan J. Melenhorst, PhD, Pamela A Shaw, PhD, Anna Sparrow, David T Teachey, MD, Mark Duckworth, BS, Carl H. June, MD, Stephan A. Grupp, MD PhD

Blood (2015) 126 (23): 3769.

https://doi.org/10.1182/blood.V126.23.3769.3769

Published: 2015

Journal Articles

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela A Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MD PhD, Colleen Callahan, MSN, Simon F. Lacey, PhD BS, Bruce L. Levine, PhD, J Joseph Melenhorst, PhD, Laura Motley, RN, Susan R. Rheingold, MD, David T Teachey, MD, Patricia A. Wood, MD PhD, David Porter, MD, Carl H. June, MD

Blood (2015) 126 (23): 681.

https://doi.org/10.1182/blood.V126.23.681.681

Published: 2015

Journal Articles

Efficacy and Safety of Humanized Chimeric Antigen Receptor (CAR)-Modified T Cells Targeting CD19 in Children with Relapsed/Refractory ALL

Blood (2015) 126 (23): 683.

https://doi.org/10.1182/blood.V126.23.683.683

Published: 2015

Journal Articles

Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice

Paritha I. Arumugam, Eric S. Mullins, Shiva Kumar Shanmukhappa, Brett P. Monia, Anastacia Loberg, Maureen A. Shaw, Tilat Rizvi, Janaka Wansapura, Jay L. Degen, Punam Malik

Blood (2015) 126 (15): 1844–1855.

https://doi.org/10.1182/blood-2015-01-625707

Published: 2015

Includes: Supplemental data

Journal Articles

Platelet FcγRIIA Signaling Results in Ubiquitination and Cellular Translocation of Activated Syk

Shaji Abraham, PhD, Leonard C. Edelstein, PhD, Chad A Shaw, PhD, Pierrette Andre, MS, Xianguo Kong, MD, Carol T Dangelmaier, Alexander Tsygankov, PhD, Paul F Bray, MD, Satya P. Kunapuli, PhD, Steven E. McKenzie, MD PhD

Blood (2014) 124 (21): 2761.

https://doi.org/10.1182/blood.V124.21.2761.2761

Published: 2014

Journal Articles

Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race

Leonard C. Edelstein, Lukas M. Simon, Cory R. Lindsay, Xianguo Kong, Raúl Teruel-Montoya, Benjamin E. Tourdot, Edward S. Chen, Lin Ma, Shaun Coughlin, Marvin Nieman, Michael Holinstat, Chad A. Shaw, Paul F. Bray

Blood (2014) 124 (23): 3450–3458.

https://doi.org/10.1182/blood-2014-04-572479

Published: 2014

Includes: Supplemental data

Journal Articles

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

Lukas M. Simon, Leonard C. Edelstein, Srikanth Nagalla, Angela B. Woodley, Edward S. Chen, Xianguo Kong, Lin Ma, Paolo Fortina, Satya Kunapuli, Michael Holinstat, Steven E. McKenzie, Jing-fei Dong, Chad A. Shaw, Paul F. Bray

Blood (2014) 123 (16): e37–e45.

https://doi.org/10.1182/blood-2013-12-544692

Published: 2014

Includes: Supplemental data

Journal Articles

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

Susan Price, Pamela A. Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, Michael J. Lenardo

Blood (2014) 123 (13): 1989–1999.

https://doi.org/10.1182/blood-2013-10-535393

Published: 2014

Includes: Supplemental data

Journal Articles

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

Blood (2014) 123 (6): 809–821.

https://doi.org/10.1182/blood-2013-07-515528

Published: 2014

Includes: Supplemental data

NARROW

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Diminished Renal Pathology in a Mouse Model of Sickle Cell Anemia in Which Fibrinogen Binding to Mac-1 Is Inhibited

Plasmin-Mediated Fibrinolysis Enables Macrophage Migration Via Liberation from Fibrin-α M β 2 Interactions

Mice Lacking Factor XIII Have Significant Protection from the Progression of Neuroinflammatory Disease

Biomarker Profiling Differentiates Sepsis from Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

Plasmin(ogen) Mediates Macrophage Migration in a Fibrin(ogen) Dependent Mechanism

Allogeneic Stem Cell Transplantation in Patients ≥70 Years Old

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice

Anti–miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice

Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS/Combined Relapsed/Refractory ALL

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

Efficacy and Safety of Humanized Chimeric Antigen Receptor (CAR)-Modified T Cells Targeting CD19 in Children with Relapsed/Refractory ALL

Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice

Platelet FcγRIIA Signaling Results in Ubiquitination and Cellular Translocation of Activated Syk

Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only